Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Apyx Medical Corporation

    NASDAQ: APYX · Real-Time Price · USD
    2.12
    -0.12 (-5.36%)
    At close: Jun 27, 2025, 3:54 PM

    Apyx Medical Statistics

    Share Statistics

    Apyx Medical has 37.79M shares outstanding. The number of shares has increased by 9.09% in one year.

    Shares Outstanding

    n/a
    		 37.79M

    Shares Change (YoY)

    n/a
    		 9.09%

    Shares Change (QoQ)

    n/a
    		 0.4%

    Owned by Institutions (%)

    n/a
    		 45.97%

    Shares Floating

    n/a
    		 32.17M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,039

    FTD / Avg. Volume

    n/a
    		 1.55%

    Short Selling Information

    The latest short interest is 299.31K, so 0.79% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 299.31K

    Short % of Shares Out

    n/a
    		 0.79%

    Short % of Float

    n/a
    		 0.85%

    Short Ratio (days to cover)

    n/a
    		 4.48

    Valuation Ratios

    The PE ratio is -2.39 and the forward PE ratio is -4.48. Apyx Medical's PEG ratio is -0.11.

    PE Ratio

    n/a
    		 -2.39

    Forward PE

    n/a
    		 -4.48

    PS Ratio

    n/a
    		 1.17

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 3.95

    P/FCF Ratio

    n/a
    		 -2.99

    PEG Ratio

    n/a
    		 -0.11
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Apyx Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.26, with a Debt / Equity ratio of 2.73.

    Current Ratio

    n/a
    		 5.26

    Quick Ratio

    n/a
    		 4.56

    Debt / Equity

    n/a
    		 2.73

    Debt / EBITDA

    n/a
    		 -2.31

    Debt / FCF

    n/a
    		 -2.07

    Interest Coverage

    n/a
    		 -3.19

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $218,645.45

    Profits Per Employee

    n/a
    		 $-106,650

    Employee Count

    n/a
    		 220

    Asset Turnover

    n/a
    		 0.74

    Inventory Turnover

    n/a
    		 2.48

    Taxes

    Income Tax

    n/a
    		 252K

    Effective Tax Rate

    n/a
    		 -1.08%

    Stock Price Statistics

    The stock price has increased by 56.74% in the last 52 weeks. The beta is 1.2, so Apyx Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.2

    52-Week Price Change

    n/a
    		 56.74%

    50-Day Moving Average

    n/a
    		 1.45

    200-Day Moving Average

    n/a
    		 1.37

    Relative Strength Index (RSI)

    n/a
    		 64.65

    Average Volume (20 Days)

    n/a
    		 196,364

    Income Statement

    In the last 12 months, Apyx Medical had revenue of 48.1M and earned -23.46M in profits. Earnings per share was -0.66.

    Revenue

    n/a
    		 48.1M

    Gross Profit

    n/a
    		 29.36M

    Operating Income

    n/a
    		 -18.84M

    Net Income

    n/a
    		 -23.46M

    EBITDA

    n/a
    		 -16.8M

    EBIT

    n/a
    		 -17.4M

    Earnings Per Share (EPS)

    n/a
    		 -0.66
    Full Income Statement

    Balance Sheet

    The company has 31.74M in cash and 38.76M in debt, giving a net cash position of -7.02M.

    Cash & Cash Equivalents

    n/a
    		 31.74M

    Total Debt

    n/a
    		 38.76M

    Net Cash

    n/a
    		 -7.02M

    Retained Earnings

    n/a
    		 -77.91M

    Total Assets

    n/a
    		 60.16M

    Working Capital

    n/a
    		 42.34M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -18.05M and capital expenditures -722K, giving a free cash flow of -18.77M.

    Operating Cash Flow

    n/a
    		 -18.05M

    Capital Expenditures

    n/a
    		 -722K

    Free Cash Flow

    n/a
    		 -18.77M

    FCF Per Share

    n/a
    		 -0.53
    Full Cash Flow Statement

    Margins

    Gross margin is 61.04%, with operating and profit margins of -39.18% and -48.78%.

    Gross Margin

    n/a
    		 61.04%

    Operating Margin

    n/a
    		 -39.18%

    Pretax Margin

    n/a
    		 -48.45%

    Profit Margin

    n/a
    		 -48.78%

    EBITDA Margin

    n/a
    		 -34.93%

    EBIT Margin

    n/a
    		 -39.18%

    FCF Margin

    n/a
    		 -39.02%

    Dividends & Yields

    APYX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for APYX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.33

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist